Abstract：A one-year-old girl visited the hospital due to limb torsion and developmental regression for one month after hand, foot and mouth disease. At the age of 11 months, she visited a local hospital due to fever for 5 days and skin rash with frequent convulsions for 2 days and was diagnosed with severe hand, foot and mouth disease, viral encephalitis, and status epilepticus. Brain MRI revealed symmetric abnormal signals in the bilateral basal ganglia, bilateral thalamus, cerebral peduncle, bilateral cortex, and hippocampus. She was given immunoglobulin, antiviral drugs, and anticonvulsant drugs for 2 weeks, and the effect was poor. Blood and urine screening for inherited metabolic diseases were performed to clarify the etiology. The analysis of urine organic acids showed significant increases in glutaric acid and 3-hydroxyglutaric acid, which suggested glutaric aciduria type 1, but her blood glutarylcarnitine was normal, and free carnitine significantly decreased. After the treatment with low-lysine diets, L-carnitine, and baclofen for 1 month, the patient showed a significant improvement in symptoms. Hand, foot and mouth disease is a common viral infectious disease in children, and children with underlying diseases such as inherited metabolic diseases and immunodeficiency may experience serious complications. For children with hand, foot and mouth disease and unexplained encephalopathy,inherited metabolic diseases should be considered.
FENG Li-Fang,CHEN Xiao-Hong,LI Dong-Xiao et al. Limb torsion and developmental regression for one month after hand, foot and mouth disease in an infant[J]. CJCP, 2016, 18(5): 426-430.
Mushimoto Y, Fukuda S, Hasegawa Y, et al. Clinical and molecular investigation of 19 Japanese cases of glutaric acidemia type 1[J]. Mol Genet Metab, 2011, 102(3): 343-348.
[9]
Kolker S, Christensen E, Leonard JV, et al. Diagnosis and management of glutaric aciduria type I--revised recommendations[J]. J Inherit Metab Dis, 2011, 34(3): 677-694.
[10]
Fu X, Gao H, Tian F, et al. Mechanistic effects of amino acids and glucose in a novel glutaric aciduria type 1 cell model[J]. PLoS One, 2014, 9(10): e110181.
[11]
Mohammad SA, Abdelkhalek HS, Ahmed KA, et al. Glutaric aciduria type 1: neuroimaging features with clinical correlation[J]. Pediatr Radiol, 2015, 45(11): 1696-1705.
[12]
Goodman SI, Markey SP, Moe PG, et al. Glutaric aciduria; a "new" disorder of amino acid metabolism[J]. Biochem Med, 1975, 12(1): 12-21.
[13]
Sauer SW, Opp S, Hoffmann GF, et al. Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I[J]. Brain, 2011, 134(Pt 1): 157-170.
[14]
Wang Q, Li X, Ding Y, et al. Clinical and mutational spectra of 23 Chinese patients with glutaric aciduria type 1[J]. Brain Dev, 2014, 36(9): 813-822.
[15]
Lee CS, Chien YH, Peng SF, et al. Promising outcomes in glutaric aciduria type I patients detected by newborn screening[J]. Metab Brain Dis, 2013, 28(1): 61-67.
[16]
Niu DM, Chien YH, Chiang CC, et al. Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan[J]. J Inherit Metab Dis, 2010, 33(Suppl 2): S295-305.
[17]
Yang L, Yin H, Yang R, et al. Diagnosis, treatment and outcome of glutaric aciduria type I in Zhejiang Province, China[J]. Med Sci Monit, 2011, 17(7): H55-H59.
Heringer J, Boy SP, Ensenauer R, et al. Use of guidelines improves the neurological outcome in glutaric aciduria type I[J]. Ann Neurol, 2010, 68(5): 743-752.
[23]
Prietsch V, Lindner M, Zschocke J, et al. Emergency management of inherited metabolic diseases[J]. J Inherit Metab Dis, 2002, 25(7): 531-546.
